Check our latest news and where we are going to be soon.
The European Commission Awards a proposal from Biohope with The Seal of Excellence Certificate.
The Seal of Excellence Certificate is a quality label awarded by the Commission to projects by companies which have been assessed in a call for proposals under a Union instrument and comply with its quality requirements. The
Dra. Isabel Portero included in the report “Referent Women in Innovative Entrepreneurship in Spain”
The report, based on surveys, has been done and coordinated by the High Commissioner of Entrepreneurship in Spain, which is an organism of the Government Presidency. This recognition reflects the role Dra. Portero is doing in
Immunobiogram® has been granted a US patent by USPTO
Biohope´s lead product, the Immunobiogram®, has been granted a US patent by the United States Patent and Trademark Office. This new patent complements and consolidates Biohope´s intellectual property protection facilitating the commercial expansion in a key market
Podcast Woman Business. Isabel Portero, CEO de BIOHOPE
“La audacia no hay que asociarla a un perfil de joven promesa o a una franja de edad” "En este episodio hablamos con Isabel Portero, una médica de profesión, especialista en Medicina Interna, que trabajaba en
Biohope Finalist and Honorable Mention at the Innovation Challenge “Thriving with Transplantation”
Biohope had an outstanding result at the 2021 Lyfebulb-CSL Behring Innovation Challenge recently celebrated, by becoming a finalist and receiving an honorable mention form the jury. The goal of the Innovation Challenge: Thriving with Transplantation ,
Biohope Partners with Palex Medical to Commercialize the Product Immunobiogram®- Renal Transplant in Spain.
Madrid, March 2021 – Biohope, a Spanish biotechnological company that investigates, develops and commercializes unique medical solutions in the field of chronic inflammation and autoimmune diseases, has signed with Palex Medical an exclusive market agreement for
Recent Publication by Biohope in Frontiers in Immunology.
The prestigious international journal, “Frontiers in Immunology”, has recently published a paper about the Immunobiogram technology, called “The Immunobiogram, a Novel In Vitro Assay to Evaluate Treatment Resistance in Patients Receiving Immunosuppressive Therapy” . Frontiers in Immunology is a leading journal in its field,
Biohope reached the CE Mark for the IMMUNOBIOGRAM®
In October, Biohope reached the CE Mark for the IMMUNOBIOGRAM®, a first in class IVD test for the in-vitro measurement of metabolic activity of patient’s immune cells as response to individual immunosuppressive drugs. Therefore, for patients
Biohope revoluciona el tratamiento con inmunosupresores
Este es el titulo del reportaje que Es Radio libertad digital dedicó a Biohope en su programa Sin Complejos durante el cual se entrevistó a Isabel Portero (26/09/2020). Escucha la entrevista aquí
Biohope presents further results from the Transbio International Study at The Transplant Society Congress (TTS 2020)
The Transplant Society Congress took place from September 13th-16th, and gathered the latest science and innovations in the field of transplantation worldwide. More than 3,000 scientists, researchers and physicians representing over 130 countries attended from their